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Background
Infection is the major complication of shunt placement
for hydrocephalus. Propioni-bacterium acnes is an anaero-
bic Gram positive rod-shaped skin bacterium, and a rec-
ognised cause of shunt infections. The clinical
presentation in P. acnes shunt infections is delayed, and is
under-diagnosed due to lack of anaerobic culture condi-
tions and the need for laboratory incubation periods of at
least 14 days. As the evidence supporting antimicrobial
prophylaxis for shunt infections is weak, antimicrobial
catheters have been developed. This project aimed to eval-
uate the protective effect of an antimicrobial shunt cathe-
ter, Bactiseal®  (Johnson & Johnson Professional Inc.,
Raynham, USA), against P. acnes and to monitor the
development of resistance by this bacterium.
Materials and methods
Bactiseal®  shunt catheters were supplied by Codman.
Three methods were used to evaluate the antimicrobial
activity of the catheter. The Serial Plate Transfer Test
(SPTT) is a screening test for the duration of antimicrobial
activity and to monitor resistance. Catheter segments were
placed onto agar plates seeded with P. acnes and incu-
bated anaerobically. Every 7 days, segments were removed
and placed on fresh plates and reincubated. The inhibi-
tion zone was measured across the short axis. This was
repeated until no inhibition zones were seen. In the sec-
ond method, time taken to kill 100% of P. acnes attached
to catheter segments (tK100) was determined by allowing
P. acnes to adhere to plain and antimicrobial catheter seg-
ments and incubating them. Three samples were retrieved
daily, sonicated to remove the adherent bacteria, and the
sonicate cultured quantitatively to detect P. acnes growth.
Thirdly, a simulated in vitro model was used to determine
the ability of the antimicrobial shunt catheters to resist
successive P. acnes challenges every 14 days under con-
stant perfusion, designed to mimic the CSF flow.
Results
The SPTT showed duration of antimicrobial activity for 70
days. The tK100 showed that it takes 96 hours to kill all
the P. acnes attached to the catheter. The in vitro model
showed that the catheters protected against P. acnes colo-
nization after 5 successive challenges (ie up to 70 days).
Also, no resistance was found.
Conclusion
This is the first in vitro study to evaluate the antimicrobial
activity of Bactiseal® against P. acnes. The findings of this
study indicate that the antimicrobial catheter is likely to
reduce shunt infections caused by P. acnes.
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